Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Evaluable Patients

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Apr 14, 2024 7:03pm

178 Views

Post# 35988487

RE:RE:Evaluable Patients

I think this all boils down to funds,no money, hard to market these sites, hard to market our treatment, a .12 cent stock price on a canadian exchange, we need to push and shove to get this done, it just takes 1 big pharma to realize the money to be made off this technology and we will all be rich, hope im not dreaming after waiting all this time

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market